Elbow Replacement Surgery in India and UAE | Complete Patient Guide

• ELIGIBLE PATIENTS:

• End-stage elbow osteoarthritis unresponsive to ≥6 months of conservative management (NSAIDs, corticosteroid injections, physical therapy, viscosupplementation)

• Rheumatoid or inflammatory arthritis with radiographic Larsen Grade IV–V joint destruction and persistent pain despite disease-modifying antirheumatic drug (DMARD) or biologic therapy

• Post-traumatic arthritis following prior distal humeral fracture, radial head fracture, or elbow dislocation

• Acute severely comminuted distal humeral fractures in patients >65 years where internal fixation is not feasible (primary arthroplasty)

• Distal humeral tumors requiring resection with prosthetic reconstruction

• Patients with functional arc of motion <100° and pain VAS ≥7/10 significantly impacting quality of life

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Plain radiographs (AP, lateral, oblique views) to assess joint space, bone stock, deformity, and prior implants

• CT scan with 3D reconstruction for detailed bone stock assessment, deformity correction planning, and implant templating

• MRI if soft-tissue pathology (e.g., collateral ligament integrity, synovitis, nerve compression) needs evaluation

• Nerve conduction studies / EMG if ulnar neuropathy (cubital tunnel syndrome) is suspected

• Full pre-operative blood panel: CBC, CMP, coagulation profile (PT/INR, aPTT), HbA1c (target <8.0% for surgical clearance), ESR/CRP (inflammatory markers)

• Echocardiogram (ECHO) and ECG for cardiac clearance in patients >60 years or with known cardiovascular disease

• Chest X-ray and pulmonary function tests if respiratory comorbidities are present

• Rheumatology clearance and temporary cessation protocol for biologics (e.g., hold TNF-α inhibitors ≥1 week pre-op per EULAR guidelines) in rheumatoid patients

• Dental clearance to eliminate occult oral infection foci before implanting prosthetic hardware

• Nutritional assessment: albumin >3.0 g/dL and prealbumin >15 mg/dL recommended to minimize wound healing complications

• CONTRAINDICATIONS (ABSOLUTE):

• Active local or systemic infection (septic arthritis, osteomyelitis, bacteremia)

• Nonfunctional triceps mechanism with no reconstructive option

• Profound bone loss precluding secure implant fixation with no bone grafting solution

• Active malignancy with uncontrolled systemic disease (relative, case-by-case assessment)

• Severe, uncontrolled neuromuscular disorders affecting the upper extremity

• Patient non-compliance with post-operative weight-bearing restrictions (critical: TEA patients must permanently restrict single-arm lifting to ≤2.3 kg / 5 lbs)

• RELATIVE CONTRAINDICATIONS:

• Poorly controlled diabetes (HbA1c >9%), active smoker (strong recommendation to cease ≥6 weeks pre-op), morbid obesity (BMI >40), significant osteoporosis without augmentation strategy

SURGICAL APPROACHES:

1. TOTAL ELBOW ARTHROPLASTY (TEA) — LINKED (SEMI-CONSTRAINED) DESIGN

The most commonly performed procedure worldwide for rheumatoid arthritis and complex fractures. The Bryan-Morrey posterior approach (triceps-reflecting or triceps-sparing) provides excellent joint exposure. The humeral and ulnar components are linked via a snap-fit axle allowing ±6–8° of varus-valgus laxity, which reduces stress at the cement-bone interface and prevents catastrophic dislocation. Implant systems include the Coonrad-Morrey (Zimmer Biomet), the Discovery Elbow System (Biomet), and the Latitude EV (Wright Medical). Cemented fixation with antibiotic-impregnated polymethylmethacrylate (PMMA) is standard. Ulnar nerve transposition is performed routinely by most surgeons to prevent post-operative cubital tunnel syndrome.

2. TOTAL ELBOW ARTHROPLASTY — UNLINKED (UNCONSTRAINED / CONVERTIBLE) DESIGN

Preferred in patients with intact collateral ligaments and adequate bone stock, particularly in younger, higher-functioning patients. Requires precise soft-tissue balancing. Examples: Kudo Type 5, Souter-Strathclyde, and the Latitude EV system in unlinked mode. The lower degree of rotational constraint translates to reduced aseptic loosening rates, but dislocation risk is higher if ligamentous reconstruction is inadequate. Several modern designs are 'convertible,' allowing intraoperative decision to link or unlink based on soft-tissue assessment.

3. PARTIAL / HEMI ELBOW ARTHROPLASTY

• Radial Head Arthroplasty: Indicated for comminuted radial head fractures (Mason Type III–IV) or after radial head excision causing instability. Modular metallic radial head prostheses (e.g., Evolent, Katalyst) restore the lateral column stabilizer, preventing proximal radial migration and valgus instability.

• Distal Humeral Hemiarthroplasty: Replaces only the distal humerus in acute fractures with preserved ulnar articular cartilage, conserving native bone stock for potential future revision.

4. REVISION ELBOW ARTHROPLASTY

Indicated for aseptic loosening, periprosthetic joint infection (PJI), component fracture, or polyethylene bushing wear. Significantly more complex than primary arthroplasty; requires structural allograft or custom implants. Performed at tertiary centers only. A two-stage approach (implant explantation → antibiotic spacer → reimplantation after 6–8 weeks) is the gold standard for confirmed PJI.

5. ALTERNATIVE JOINT-PRESERVING PROCEDURES (for candidates not yet requiring arthroplasty):

• Arthroscopic elbow debridement and osteophyte resection (outerbridge-kashiwagi / ulnohumeral arthroplasty technique): appropriate for early-to-moderate osteoarthritis with preserved joint space

• Synovectomy (arthroscopic or open): for inflammatory/rheumatoid synovitis prior to cartilage destruction

• Interpositional arthroplasty (fascia lata or Achilles allograft): historical procedure now rarely performed

• These are discussed during consultation; GAF Healthcare surgeons perform joint-preservation procedures where clinically appropriate, reserving arthroplasty for indicated cases

6. ANESTHESIA & PAIN MANAGEMENT TECHNOLOGY:

• Ultrasound-guided brachial plexus nerve block (infraclavicular or axillary approach) as primary anesthetic with light sedation, or combined with general anesthesia for intraoperative tourniquet tolerance

• Continuous peripheral nerve catheters (perineural infusion) for 48–72 hours post-operative analgesia — reduces systemic opioid consumption by 60–70%

• Perioperative tranexamic acid (TXA) administration to minimize surgical blood loss

• Intraoperative fluoroscopy / C-arm imaging for real-time component position verification

• Select centers in India and UAE offer intraoperative navigation assistance for revision cases with significant bone deformity

PRE-OPERATIVE PHASE (Weeks 1–3 before surgery):

Step 1 — Remote Case Evaluation (Days 1–7): Patient submits existing imaging (X-rays, CT/MRI), blood reports, and a detailed medical history to GAF Healthcare's clinical coordination team. A board-certified orthopedic surgeon reviews the case within 48 hours and issues a detailed written opinion, recommended implant type, and a cost estimate.

Step 2 — Medical Visa & Travel Arrangements (Days 7–14): GAF Healthcare assists with India e-Medical Visa (IVAS) application or UAE entry visa processing. Appointments at the destination hospital are confirmed. Pre-operative dietary, medication (biologic cessation protocol for RA patients), and physiotherapy preparation instructions are issued.

Step 3 — Arrival & Pre-Operative Assessment (Days 1–2 in-country): Patient is received at the airport with a dedicated GAF Healthcare coordinator. Pre-operative workup is consolidated into a single-day protocol: anesthesia assessment, ECHO (if indicated), final blood panel, 3D CT imaging (if not already done), and surgical consent documentation. Smoking cessation and nutritional optimization are confirmed.

INTRA-OPERATIVE PHASE (Day 3):

Step 4 — Surgery (3–4 hours operative time): Procedure performed under ultrasound-guided brachial plexus block ± general anesthesia. Bryan-Morrey or triceps-sparing posterior approach. Components cemented, ulnar nerve transposition performed as indicated. Intraoperative fluoroscopy confirms component alignment and range of motion. Wound closed over a deep drain.

POST-OPERATIVE PHASE — In-Country:

Step 5 — ICU/Recovery & Ward (Days 1–2 post-op): Patient monitored in recovery for neurovascular status of the hand (capillary refill, sensation, grip). Continuous peripheral nerve catheter provides pain control. Drain removed at 24–48 hours. Elbow placed in a posterior splint at 90° flexion.

Step 6 — Early Mobilization (Days 2–5 post-op): Hospital physiotherapist initiates gentle active-assisted range-of-motion exercises. Splint transitioned to a removable thermoplastic splint. Patient and attendant educated on wound care, activity restrictions (critically: no lifting >2.3 kg / 5 lbs for life with the operated arm), and red-flag symptoms of infection.

Step 7 — Discharge & Outpatient Recovery (Days 5–21): Patient discharged to GAF Healthcare-arranged accommodation. Outpatient physiotherapy sessions 3–5 times per week focusing on progressive range-of-motion restoration, edema management, and light functional activities. Wound review and suture/staple removal at 10–14 days.

Step 8 — Fit-to-Fly Assessment (Weeks 3–6): Surgeon conducts clinical review and wound inspection. Short-haul passengers (<5 hours) are typically cleared at 3–4 weeks post-op. Intercontinental travelers (>6 hours) are cleared at 5–6 weeks. Deep vein thrombosis (DVT) prophylaxis with low-molecular-weight heparin (LMWH, e.g., enoxaparin) is prescribed for the flight.

POST-RETURN RECOVERY MILESTONES:

• 6 weeks: Transition to active physiotherapy; begin light functional use of the arm (writing, eating)

• 3 months: Most patients achieve a functional arc of motion (30°–130° flexion) and return to light desk work

• 6 months: Plateau of functional improvement; approximately 90% of patients report meaningful pain reduction

• 12 months: Final outcome assessment; revision of physiotherapy goals if stiffness persists

• Permanent restriction: No single-arm lifting >2.3 kg (5 lbs); no impact activities or contact sports with the operated arm — this is non-negotiable for implant longevity